Medicine recalls
|
| |
| Canada: Recall: Sandoz Fesoterodine Fumarate 8 mg tablet; Out of specification (Diester impurity) |
| |
Health Canada announces that Sandoz Canada Incorporated is recalling two lots of Sandoz Fesoterodine Fumarate 8 mg tablet (extended-release) (lot numbers: 2305011683 and 2305012068) from retailers because the Diester impurity is out of specification in the affected lots.
The product is indicated for the treatment of patients with overactive bladder with symptoms of urinary frequency, urgency, or urge incontinence, or any combination of these symptoms.
Please refer to the following website in Health Canada for details:
http://recalls-rappels.canada.ca/en/alert-recall/sandoz-fesoterodine-fumarate-8-mg-tablet-out-specification-diester-impurity-0
In Hong Kong, the above product is not a registered pharmaceutical product. Related news was previously issued by Health Canada, and was posted on the Drug Office website on 17 May 2024 and 10 Dec 2024.
Ends/Saturday, Mar 22, 2025
Issued at HKT 12:00
|
| |
|
